Harrison Clinical Research Group GmbH Establishes West Coast Office, Appoints New USA Director of Clinical Operations

Melissa Carbon, MA, CCRP assumes Director position, opens California HCRAmerica
office
PRINCETON, N.J. & MUNICH, Germany--(Business Wire)--
The Harrison Clinical Research Group GmbH, a leading full-service,
scientifically and medically driven clinical research organization with offices
worldwide, is pleased to announce that Melissa Carbon has joined the company as
Director, Clinical Operations of HCRAmerica, our USA affiliate, based in its
West Coast, California office. Ms. Carbon is responsible for providing strategic
operational leadership and overseeing the management of North American and
International Phase I-IV clinical trials. Ms. Carbon excels at building
effective sponsor-CRO relationships and is a highly accomplished International
clinical trials specialist having successfully managed more than 100 clinical
trials for CNS, CV, Oncology, GI, ID and other therapeutic indications over the
past 14 years.

Prior to joining HCRAmerica, Ms. Carbon held the position of Director of
Clinical Operations for Advanced Biomedical Research, Inc. (ABR). Ms. Carbon
worked at ABR for over 10 years under the leadership of founder, Dr. Michael S.
Willett. Melissa played a key role in managing pivotal Phase III CNS and
oncology clinical trials in adult and pediatric patient populations among her
many accomplishments at ABR. Ms. Carbon also previously helped to start up the
San Diego office of Scirex (now part of Premier Research). Ms. Carbon received
her undergraduate degree from San Diego State University and her Master of
Psychology degree from Chapman University.

Dr. Francisco Harrison, founder of HCR commented, "I am delighted to welcome
Melissa to our company. She brings talent, experience and boundless energy and
enthusiasm to our company. Her experience in working with US, European and
Japanese clients and Investigators from around the world will be a tremendous
asset to us." Dr. Michael Willett added that, "As we continue to grow our
American presence, I am especially pleased to be reunited with Melissa here at
HCRAmerica. Melissa has a unique passion for clinical trials and brings her
special talent for building and motivating high performance project teams to
HCR. Her customer-centric approach creates durable relationships with clients
who quickly come to appreciate they can rely on Melissa and her team to deliver
high quality results on-time and within budget."

About HCRAmerica and Harrison Clinical Research Group GmbH

HCRAmerica is the US affiliate of Harrison Clinical Research Group GmbH, a
full-service Phase I-IV global CRO with a staff of over 400 clinical research
professionals and offices in 12 countries throughout the USA, Europe and Russia.
HCR also has well established partners in the USA, Canada, Scandinavia, South
America, South Africa, Australia, India and Japan. HCR has a 22-year track
record of service excellence in providing timely and reliable performance of
clinical trials. HCR has the understanding and strategic network to offer a full
range of clinical research activities throughout the USA, Europe and worldwide.
Our team is proud of its quality and is ISO 9001 certified for the performance
of Phase I, II, III and IV clinical trials.

Harrison Clinical Research ■ Outsourcing Dedication ■ www.harrisonclinical.com

Harrison Clinical Research Group GmbH
Francisco Harrison, MD, +49 89-126680-0
Chairman
Albrechtstrasse 43, 80636 München, Germany
francisco.harrison@harrison-cro.com
or
HCRAmerica, LLC
Michael S. Willett, PharmD, +1 609-987-1700
President & Managing Director
michael.willett@harrison-cro.com
or
HCRAmerica, LLC
Melissa R. Carbon, MA, CCRP,+1 951-272-2084
Director Clinical Operations
melissa.carbon@harrison-cro.com

Copyright Business Wire 2009